elizabethmock1248-blog - Tumblr blog

[elizabethmock1248-blog]

IT Spending On Clinical Analytics Market Will Generate New Growth Opportunities by 2019

Over the past few decades, there has been a significant transition in the healthcare industry. It has witnessed tremendous growth due to the high demand of value-based care for population health in all parts of the globe and has transformed from a manually-operated sector to a digitally managed one. This synchronization of digital and physical worlds has started generating mammoth volumes of patient data, proper analysis of which can lead to bountiful benefits such as reduction in the numbers of patient readmission in hospitals and improved clinical outcomes, to name a few. Vast improvements in financial and clinical decision support management are also made possible by critical analysis of data generated by healthcare systems.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16748

A greater understanding of these factors, coupled with the rising adoption of digital data management tools in healthcare settings is leading to a vast rise in expenditure on clinical analytics systems and solutions. Transparency Market Research (TMR) estimates that the global IT spending on clinical analytics will rise manifolds in the years to come. According to this report by TMR, IT spending on clinical analytics across the globe valued at US$11,650 mn in 2015. Expanding at a remarkable 12.3% CAGR over the period between 2016 and 2024, this is projected to reach US$32,422 mn by 2024.

In the report, the IT spending on clinical analytics is segmented on the basis of platform into stand-alone and integrated. Of these, the segment of integrated clinical analytics solutions acquired the dominant chunk of revenues of the global market in 2015 and is expected to maintain dominance over the forecast period as well.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16748

The global market for biological drugs is spread across Europe, North America, Asia Pacific, and the Rest of the World. Thanks to the increased application of biological drugs for the treatment of a number of diseases, such as diabetes, cancer, and other chronic medical conditions, North America has emerged as the leading consumer of biological drugs. Over the forthcoming years, investments to increase research and development activities in biological drugs is likely to heighten, which consequently, is expected to boost the North America biological drugs to a great extent. Expanding at a CAGR of 10.90%, this region will continue to hold the leadership in the global market for biological drugs during the forecast period. 

Report Details at https://www.transparencymarketresearch.com/it-spending-on-clinical-analytics-market.html

In terms of geography, the market is dominated by North America and the region will continue to constitute the bulk of share in the global market by the end of the forecast period as well. The region leads in terms of IT spending on clinical analytics owing chiefly to the technologically advanced healthcare infrastructure, favorable government policies, and increased incentives. The IT spending on clinical analytics in North America is estimated to be valued at US$5,349 mn by the end of 2016 and is expected to expand at a CAGR of 10.8% to reach US$12,110 mn by 2024.

However, North America is expected to lose to Asia Pacific in terms of rate of growth over the forecast period; IT spending on clinical analytics in Asia Pacific is expected to expand at a remarkable 16.9% by 2024. The region will see the adoption of clinical analytics at such a rapid pace owing to vast technological advancements, enhancement and rapid digitization of healthcare infrastructure, and increased adoption big data and analytics in healthcare. Japan is a highly attractive market in the region, followed by China and India. Other APAC countries are also expected to emerge as highly promising markets for clinical analytics in the next few years owing to similar factors.

Some of the key players in clinical analytics are McKesson Corporation, Cerner Corporation, IBM Corporation, Optum, Inc., Allscripts Healthcare Solutions, Inc., Oracle Financial Services Software Limited, CareCloud Corporation, Medical Information Technology, Inc., Hewlett-Packard Enterprise Development LP and ArborMetrix, Inc.

[elizabethmock1248-blog]

3D Printing in Medical Applications Market: Growth and Sales Forecast 2023

The 3D printing technology has revolutionized several industries by enabling non-conventional, faster, and economic manufacturing of a variety of products possible. The potential uses of this technology are being uncovered at a rapid pace across the medical industry and many revolutionary medical applications of 3D printing are expected to be uncovered in the next few years. Transparency Market Research states that the global 3D printing for medical applications market will exhibit growth at a promising pace and will enable significant transformations in the field of healthcare in the near future. The market is expected to rise to a valuation of US$965.5 mn by 2019.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1522

On the basis of key applications, the market for 3D printing in the medical field has been segmented in the report into implants, surgical instruments, bioengineering, and surgical guides. Of these, the segment of implants accounted for the dominant share in the global market, valuing at nearly US$337.3 mn in 2015. The segment is expected to exhibit growth at a significant pace over the report’s forecast period and continue to be the dominant contributor to the global 3D printing in medical applications market over the forecast period as well. The report states that the segment of implants will have an opportunity of US$632.7 mn by 2019, accounting for over half of the overall valuation of the global market by the said year.

The immense growth prospects of the 3D printing technology across the implants application can be attributed to the increased demand for implants for a variety of orthopedic, dental, and cranio-maxillofacial disorders. The sub-segment of dental implants will account for the dominant share of revenue contributed by the segment of implants to the 3D printing for medical applications market over the forecast period.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1522

Geographically, the report examines the market for 3D printing in medical applications across regions such as North America, Europe, and Asia Pacific. Of these, the market is presently dominated by North America. The region dominates the market owing to the presence of some of the key players in the 3D printing technology in the U.S. The U.S. accounts for a significant share in the global 3D printing in medical applications market and is expected to remain the hub for future developments in the field as well. Thus, the North America 3D printing in medical applications market is expected to retain its command on the global market throughout the report’s forecast period. However, the market in Europe is expected to outpace North America owing to the rising number of 3D printing companies in the region.

Despite being a slow-growth region for several industries owing to recent economic upheavals across several countries in the past few years, the technologically advanced companies in Europe have been focusing hard on technological innovations such as 3D printing. The Europe market for 3D printing in medical applications is expected to be led by Germany, which is expected to outpace Japan in terms of growth rate in the next few years. The market is also expected to gain significant traction in Europe in the next few years owing to the favorable medical reimbursement policies and a substantial rise in funding from government bodies aimed at technological advancements.

Currently, North America holds supremacy in the global red biotechnology market followed by Europe. North America typically is a pioneer in the introduction of new products and is an early adopter of integration of advanced sciences for public welfare. Europe also exhibits strong hold in the global red biotechnology market. Emerging economies in Asia Pacific, Latin America, and the Middle East and Africa are anticipated to emerge as lucrative markets for red biotechnology in the upcoming years, owing to the need for affordable treatment for several diseases and rising healthcare expenditure in these regions.

Report Details at https://www.transparencymarketresearch.com/3d-Printing-medical-applications.html

Despite the budding stage of the global 3D printing market, companies manufacturing products for medical applications by incorporating the 3D printing technology have significantly increased in number in the recent past. Many new companies are venturing into the market at a rapid pace and are expected to enrich the market through advanced and innovative products in the near future.

Some of the key companies operating in the global 3D printing for medical applications market are Nanoscribe GmbH, 3D Systems Corporation, EnvisionTEC GmbH, Voxeljet Technology GmbH, Stratasys Ltd., and Materialise NV.

[elizabethmock1248-blog]

Vaccine Market to Witness a Pronounce Growth by 2023

Vaccination has been approved as one of the best methods for the prevention of infectious diseases by many international organizations such as the World Health Organization (WHO). The rising prevalence of diseases plays a central role in the growth of the global market for vaccines. Governments worldwide are striving to ensure good health of the people in their country. Therefore, there is a strong demand for vaccines from government bodies, various advisory and regulatory bodies that keep a check on vaccine safety and quality, pooled procurement agencies, and private sectors. Some of the vaccinations available in the market are human papillomavirus (HPV), Hepatitis A and B, influenza, meningococcal, combination vaccines, and pneumococcal.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21

The research report takes into account the historic and current scenario to estimate trends of the global vaccine market in the foreseeable future. It offers insights into statistics and dynamics pertaining to the market at both global and regional level. For a better understanding, the report segments the market on the basis of various criteria such as products and antigens. It provides a detailed analysis of the competitive landscape of the market. It profiles the key players in the market along with their market shares, latest developments, business strategies, and contact information.

Over the past few years, the global vaccine market has exhibited tremendous growth and is likely to progress at a similar pace for the forthcoming years. The low risk of serious side effects associated with vaccines is resulting in a positive response from diverse demographics. Vaccine manufacturers are working towards the improvement of existing vaccines as well as the development of new vaccines, which is also providing a significant push to the market.

However, manufacturers have to invest considerable capital and undergo stringent regulatory approval processes for the development and approval of new vaccines. The handling, storage, and transportation of vaccines involve high cost. Moreover, the global vaccine market is highly dependent on donor policies and public purchasers, which amplifies the complexity of assessing and understanding pricing and procurement.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=21

The overall dermatological diagnostics and therapeutics industry is forecast to witness tremendous growth rate and reach $38 million by the year 2013 with annual growth rate of 8.7%. Rising pressure is also forcing the companies to engage into licensing agreements and help them to expand their product portfolio and improve competitive positions in industry.

Report Details at https://www.transparencymarketresearch.com/global-vaccine-market.html

The strong foothold of players such as Pfizer Inc., GlaxoSmithKline Plc., Novartis AG, and Sanofi is making the global vaccine market a highly concentrated arena. Several key players are focusing on mergers and acquisitions to expand their business across different regions. The continuous efforts by them to develop new and effective vaccines is intensifying the competitive rivalry in the market.

The market is highly regulated and capital intensive, which is creating high entry barriers for new players. Some other prominent players in the global vaccines market are Boehringer Ingelheim, Emergent Biosolutions Inc., Bavarian Nordic, Medimmune LLC., Merck & Co. Inc., CSL Ltd., and Zoetis Inc.

[elizabethmock1248-blog]

Life Sciences Software Market Key Manufacturers, Development Trends And Competitive Analysis 2018

The life science is a field of science thatdeals with the study of living organisms such as human being, microorganism and animals. It includes wide range of areas of study for example biology, anatomy, health sciences, medical sciences or medicine. The software used in life science enables users to increase efficacy and reduce the cost of deploying valuable IT infrastructure. For example, SaaS (Software as a Service) model for life science offers a pay per use model that provides more feasibility to store patient data. 

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1969

These software’s enable organizations to securely store, record and maintain patient’s data, images, texts and data.The healthcare records and patient data being converted into electronic format with the help of these software’s enables healthcare professionals to easily access patient’s data.  Various life sciences software are commercially available in the market for differentpurpose that includes drug target identification and validation Accelrys, laboratory information management system software, clinical trial management Oracle, Argus and others.

This software system enables to effectivelystore and manage patient information data that drives the market of life science software. High cost associated with the implementation of software restrains the market growth. In addition,complex programming, additional cost for data integration and quality pose a challenge to the growth of Life Sciences Software Market.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1969

increased phase of consolidation. As this pace of consolidation gathers momentum, there is a pressing need for shared databases and records of medical histories of patients. This demand can only be addressed with the implementation of IT- and telecom-centric solutions. A number of technologies such as cloud computing, SaaS, and other software solutions developed specifically for the healthcare industry form an integral part of this trend. They are the key through which medical records and other applications can be effectively connected between healthcare facilities.

Report Details at https://www.transparencymarketresearch.com/life-sciences-software.html

Some of the key players contributing to the global life science software market comprises Accelrys Software, Inc., Cegedim SA, Medidata Solution, Inc., Oracle Corporation, Revitas, Inc., Veeva Systems, Inc., Model N, Inc., SAS Institute, Inc., TIBCO Software, Inc., Perceptive Informatics, Inc. and PTC Therapeutics, Inc.

[elizabethmock1248-blog]

The Role of IT and Telecom in Healthcare Market to make Great Impact in near Future by 2025

Information technology (IT) supports hundreds of core and peripheral operations in the healthcare industry. From storing patient data to monitoring patient health to researching optimal therapies, IT is ubiquitous in the medical and healthcare industry worldwide. This report by Transparency Market Research offers an analytical and comprehensive insight into how IT and telecom products impact the healthcare industry across its landscape. This research report takes into account key driving factors and growth restrainers that every market player should be aware of.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=99

Strategic decision making needs to be based on verifiable data, as one false step in an intensely competitive environment could mean millions of dollars lost. The report thus takes a close look at the healthcare market specifically from the standpoint of the IT and telecom industry. Opportunities for the monetization of healthcare processes form a key component of the report. Major geographies, latest market trends, and projected growth figures are cohesively documented in the report. This data forms the foundation for recommendations for future growth.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=99

Top six players of influenza vaccine manufacturers occupy more than 75% of the total influenza vaccine market. Seasonal influenza vaccine brands like Fluarix & Flulaval were one of the leading players in the market in 2010. Other key players in this market include GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals. 

Report Details at https://www.transparencymarketresearch.com/healthcare-it-telecom.html

Advancements in telecommunications and IT have made it possible to monitor patients remotely and also to use more accurate methodologies to diagnose and treat medical conditions. As a result, the quality of medical care available to patients in the developing world is poised to greatly improve. Round-the-clock monitoring has been made possible with the use of intelligent IT and telecom solutions in the health industry. Telemedicine is an area that holds immense potential, and medical establishments are looking at opportunities for investment here. Thus, the demand for IT and telecommunications products in the healthcare sector will continue to see an upward trend in the coming years.

[elizabethmock1248-blog]

Hepatitis B Therapeutics Market Growth with Worldwide Industry Analysis to 2020

Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and stops development of liver cancer and chronic disease caused by hepatitis B. It can cause a long term infection and put people at high risk of liver cancer and cirrhosis that may lead to death. Globally, hepatitis B is one of the major health problems that spreads by mucosal or percutaneous exposure as well as through menstrual, seminal, saliva, and vaginal fluids. Hepatitis B can occur due to sexual transmission, by having contact with sex workers and sex with multiple partners. Transmission of disease may also occur due to reuse of syringes and needles both among persons who inject drugs and in health care settings. Moreover, it may occur during surgical, medical, and dental procedures, and use of razors that are contaminated with infected blood. Infants and young children mostly get chronic hepatitis B.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=144

Limited access to treatment and diagnosis of hepatitis B in many resource constrained settings and increasing prevalence of hepatitis B infections are likely to drive the global hepatitis B therapeutics market during the forecast period. Rising awareness and increasing affordability are some of the key factors that will increase the rate of diagnosis before a person having advanced liver disease. According to the World Health Organization (WHO), infection of chronic hepatitis B is most common in infants. Rising incidence of hepatitis B infections is a major driver of the market. Less availability of antibiotics in the market and effectiveness of antivirals against hepatitis B infections is likely to propel the market during the forecast period. Prevalence of hepatitis B is increasing steadily across the globe. Medications and treatment options are highly expensive. These are the major drivers of the hepatitis B therapeutics market.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=144

That said, the market for HIV therapeutics potentially remains in billions, with new patent trials being conducted every year. HIV market therefore remains highly attractive in terms of novel drugs and their impact globally. Asian manufacturers are proving to be a tough competition with their unique patent laws that circumvent patent of essential life saving medicines. The prices too are bound to decrease with the entry of such manufacturers, thereby potentially increasing therapeutics market in terms of volume. The North American HIV market is the highest market globally, by value and occupies more than 50% of the global revenue generated from HIV antiviral; this is followed by the European market at around 30% of the global market. The growth in these regions is mainly attributed to high affordability of drugs along with a range of health insurance coverage. In developing markets of Asia and South America, the leading cause of death is their poor healthcare standards. This along with their population size make for a potentially large market, however unavailability of affordable drugs is often the reason why markets haven’t been proliferated as of yet. On the other hand, the recent growth of market in Asia Pacific is a positive sign for potential manufacturers. The rest of the world also follows a similar pattern like Asia. Overall the Asian, African and South American region contribute less than 20% share in the global HIV market. 

Report Details at https://www.transparencymarketresearch.com/hepatitis-b-market.html

Major players operating in the global hepatitis B therapeutics market are GlaxoSmithKline plc, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax SA, F. Hoffmann- La Roche, Novartis AG, and Merck & Co. The increasing competition among key players is likely to drive the global hepatitis B therapeutics market during the forecast period. 

[elizabethmock1248-blog]

Influenza Vaccine Market Set for Rapid Growth And Trend, by 2020

  Influenza Vaccine is also called as flu shot and is used for protection against influenza virus. An influenza vaccine is a combination of three influenza viruses namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain. Over the recent years, the

Influenza Vaccine market

has witnessed double digit growth rate due to fear of an impending pandemic. The Influenza Vaccine market has grown at a CAGR of approximately 65% between 2008 and 2010 due to the havoc caused by H1N1 virus. However, H1N1 flu vaccine demand will decline due to waning threat of swine flu epidemic. The Influenza Vaccine market is expected to cross USD 4 billion in 2015. 

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=211

Among all the geographical regions, U.S. was the largest Influenza Vaccine market in the year 2010 closely followed by China. Like any other medication, dealing with such a deadly infectious disease is a challenge still faced by healthcare units. The chances of occurrence of seasonal influenza are equal in developed as well as developing nations. And it is predicted that in next five to six years the market for seasonal influenza vaccine will increase significantly due to high infection rate across the population. 

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=211

In terms of region, the hepatitis B therapeutics market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the hepatitis B therapeutics market owing to the high awareness levels, availability of improved infrastructure, and favorable government initiatives relating to the promotion of hepatitis B therapeutics. Europe is the second largest market for hepatitis B therapeutics driven by rising geriatric population, high rates of chronic infections in Central and Eastern Europe. Prevalence of hepatitis B is the highest in Middle East & Africa where adult population is chronically infected. According to the WHO, it is estimated that 2% to 5% of general population is affected chronically in Asia Pacific. Most people with liver cancer die within diagnosis as there are limited treatment options.

Report Details at https://www.transparencymarketresearch.com/influenza-vaccine-market.html

The report analyses the global scenario of Influenza Vaccine Market discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data and forecasts the Influenza Vaccine Market size, production forecasts along with key factors driving and restraining the market.

[elizabethmock1248-blog]

Neurology Devices Market Scope and Opportunities Analysis 2018

  Increased sophistication and technological advances has paved a new path for treatment of acute and chronic neurological diseases. According to the WHO, neurological disorders constitute approximately 12% of the total deaths worldwide, of which cerebrovascular diseases are responsible for 85% of the deaths due to neurological disorders. In addition, rise in ageing population and increasing awareness of neurological disorders has triggered the growth of this industry. According to the Brain Aneurysm Foundation it is estimated that around 6 million people in the U.S. alone have unruptured brain aneurysm and the annual rate of rupture is approximately 8 to 10 per 10,000 or about 30,000 people in the U.S. suffer a aneurysm rupture. Thus rise in number of surgeries compounded with rise in incidence of neurological diseases have boosted the overall growth of neurological devices industry.

 Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=284

 Neurological devices include CSF management devices, interventional neurology, neurosurgical devices and neurostimulation devices. The neurostimulation devices market is expected to foresee the highest growth rate during the forecast period and also accounted for the largest market in year 2012. This market holds immense growth owing to the aging population in the developed economies in the world, technological advancements in the field of medical devices, increasing prevalence of lifestyle induced diseases such as obesity and depression, increasing demand for minimally invasive medical procedures and rising healthcare related consumer expenditure in the developed economies. The interventional neurology market is also expected to have a healthy growth rate after neurostimulation devices market. The neurothrombectomy devices segment of interventional neurology is expected to have a strong growth in coming years of forecast period. This growth has been attributed to rise in incidence cases of stroke and cerebral aneurysms.

 The growing burden of these diseases coupled with uncertain economic conditions in the U.S. and Europe has compelled the OEMs to introduce cost effective devices for treatment of neurological disorders. Tax reforms along with increased regulatory compliance norms are also restraining the growth and profitability of the major companies.

 Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=284

Geographically, the North American region constituted the largest market for neurological devices market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of over 18% from 2013 to 2019. This growth has been attributed to increase in respiratory disease population and rising disposable incomes coupled with change in lifestyle. In addition, economic development and healthcare reforms would increase the government funding in its intensive R&D and would trigger the growth of this market in Asia-Pacific region.

 Report Details at https://www.transparencymarketresearch.com/neurology-devices-market.html

[elizabethmock1248-blog]

Red biotechnology Market will Generate New Growth Opportunities By 2025

Red biotechnology involves the application of biotechnology in the production of biopharmaceuticals and pharmaceuticals. Biotechnology is increasingly gaining prominence in medicine over the last few years. The global biotechnology market is gaining from evolution of the healthcare industry to provide advanced diagnostics and novel line of treatment for medical conditions.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2063

Red biotechnology aka medical biotechnology involves the development of novel therapeutic procedures and advanced diagnostics. The application of biotechnology in pharmaceutical and biopharmaceutical segments involve examination of cells and tissues, stem cells, orphan drugs, pharmacogenetics, genetic testing, gene therapy, and proteomics. Red biotechnology is primarily used for neurosciences and protein research.

The application of biotechnology in pharmaceuticals has helped the healthcare industry discover line of treatment for almost 5,000 to 8,000 rare diseases that affect almost 27 to 63 million people worldwide, which represents 6-8% of the global population. Red biotechnology has also helped for the diagnosis and treatment of an array of life-threatening diseases. Furthermore, advances in biotechnology for pharmaceutical and biopharmaceutical industry have improved treatment efficacy considerably. For instance, the application of red biotechnology in the pharmaceutical industry have improved survival rate of most cancers.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2063

Geographically, North America and Europe holds a strong growth following the increasing need of digital system in life sciences. While increasing investment for infrastructure modernizationby domiciled companies in Asia-Pacific regions may potentiate the growth of life sciences software market in this region.

Report Details at https://www.transparencymarketresearch.com/red-biotechnology-market.html

Red biotechnology is the application of biotechnology in biopharmaceuticals and pharmaceuticals production. It provides patients with innovative and modern modes of diagnostics and treatments. This biotechnological application involves research and study on cells and tissues, genetic testing, stem cells, gene therapy, orphan drugs, proteomics and pharmacogenetics. The red biotechnology mainly focuses on neurosciences and protein research.

[elizabethmock1248-blog]

Dermatological Diagnostics And Therapeutics Market by Application, Trends and Growth Rate to 2020

  The

Dermatological diagnostics and therapeutics market

is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatological diagnostics market accounting for 28.7% of the total therapeutics market followed by psoriasis (26.4%), rosacea (14.9%), and atopic dermatitis (9%). 

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=423

Many new players are emerging in this market as a result of a number of growth opportunities provided by this market, thus creating tough competition. Forthcoming patent expiries of major drugs is increasing the competition, further driving this market. 

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=423

Polymer encapsulated medicines are also expected to witness an upsurge in demand depending on contributions to improved bioavailability and reduced toxicity of advanced parenteral compounds. Safety engineered prefillable syringes, IV catheters, and vial bag infusion systems are expected to provide best growth opportunities for parenteral infusion products and delivery devices due to wide infection prevention advantages. 

Report Details at https://www.transparencymarketresearch.com/dermatological-diagnostics-and-therapeutics-market.html

[elizabethmock1248-blog]

Advanced Parenteral Drug Delivery Devices Market Future Opportunities 2019

Increasing number of new biological products and emergence of new biosimilars is focusing the attention towards the development of advanced drug delivery technologies for delivery of these biological products. Currently, oral and parenteral drug delivery technologies are dominating the Advanced Parenteral Drug Delivery Devices Market. Despite various technological innovations and discovery of more compelling and effective methods for drug delivery, parenteral method remains most dominant due to its effective results.  

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=390

Parenteral drug delivery is one of the largest segments of drug delivery markets accounting for about 30% of the total market share. This industry is expected to reach $51 billion by the year 2015 owing to various factors such as introduction of new biologics, uptake of new delivery platforms, and utilization of controlled release systems. Monoclonal antibodies segment is expected to lead the market due to advancements in biotechnology and improved therapies for various disorders like cancer, and other debilitating diseases. 

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=390

Geographically, the United States and Europe market contributes a larger proportion of revenues to this product category. Owing to expensive medical treatment, demand for home care, availability of efficient reimbursement scenario and government interventions to curb per patient healthcare expenditure has driven the market in these geographies. Asia-Pacific as of now is at a very nascent stage but the with the burgeoning cardiovascular diseases and availability of high disposable income market is expected to grow at a rapid pace in coming 5-7 years.  

 Report Details at https://www.transparencymarketresearch.com/advanced-parenteral-drug-delivery-devices-market.html

[elizabethmock1248-blog]

ECG Telemetry Devices Market Size, Status and Forecast up to 2024

Cardiovascular diseases are one of the leading causes of deaths across the globe. In developing countries deaths associated with cardiovascular diseases is estimated to rise from 28.9% in 1990 to 36.3% by 2020. According to a study conducted by The Heart Foundation in every 33 seconds a person dies due to cardiovascular disease which is approximately 250,000 people every year. An electrocardiography or ECG device monitors and record electrical activity of the heart the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. This eventually helps physician or cardiologist to diagnose cardiac abnormalities as well as size and position of chambers. Technologic advances and increasing government interventions to render quality medical devices at an affordable price demand for miniature and telemetry devices have grown tremendously in past couple of years. An ECG telemetry device in majority of cases is a non-invasive product that allows continuous real time detection of patient’s cardiac rhythm and electrical activity. Signals captured by these ambulatory devices are then transmitted via radiofrequency to a central monitoring station where health care professionals can continuously monitor patient activity and are alerted to rhythm disturbances. 

 Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=362

 ECG telemetry devices are highly useful in addressing the needs of patients that are highly susceptible to cardiac disorders and require continuous medical interventions but cannot afford to stay in hospitals or private clinics. These devices are gaining lot of acceptance and support from post-coronary care units and ambulatory service providers. During an emergency situation the ambulatory care units with the help of novel ECG telemetry devices can send real time cardiac activities to hospitals or physicians which save time and makes the entire rescue process hassle free and well planned.  Major drives to the uptake of device in upcoming years encompasses demand for low cost treatment facilities among hospitals, accurate and precise homecare monitoring devices and increasing prevalence of cardiovascular disease among baby boomer populations especially in developed economic countries.

 With growing opportunities, telemetry device manufacturers are adopting several techniques to develop the next-generation devices. Government interventions to reform healthcare sector and infrastructure has inclined majority of larger hospitals towards investments related to data management systems and computerization of ECG records. Efficient data management system enhances efficiency, reduces data losses and efficient records for appropriate billing. Restraints to the market include high cost associated with initial purchase and continuous need for wireless communication mode or internet requirement which restrict the acceptance of devices in developing and emerging economies.

 Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=362

On the basis of solution, the global organ preservation solutions market has been divided into viaspan, RENOGRAF, hypoThermosol, custodiol HTK, PERFADEX, lifor human bioSystems, and siRNA Transplant Solutions. Furthermore, the key segments of the global organ preservation solutions market in terms of preservation are static cold storage, hypothermic perfusion preservation, and others. Innovations in the preservation methods is expected to offer promising opportunities for the leading market players.

From a geographical perspective, the global organ preservation solutions market can be divided into Europe, Asia Pacific, North America, and the Rest of the World. In 2012, Europe led the global market and is expected to remain in the leading position in the next few years. Thanks to the technological advancements in this field, the Europe market for organ preservation solutions is projected to register a progressive growth rate in the near future. In addition, the substantial contribution from Spain is expected to accelerate the growth of the market in the near future.

Report Details at https://www.transparencymarketresearch.com/ecg-telemetry-devices-market.html

Some of the prominent players operating in ECG Telemetry Devices market include Aerotel Medical Systems Ltd., Cardiac Science Corporation, Nihon Kohden Corporation, Philips Healthcare, Welch Allyn Inc., GE Healthcare Inc., Ltd., Mindray Medical International Ltd. Siemens Healthcare, and Medtronic Inc. among other key players. 

[elizabethmock1248-blog]

Organ Preservation Solutions Market to Record Sturdy Growth by 2020

  The global market for organ preservation solutions is expected to witness substantial growth throughout the forecast period. The rising number of opportunities through strategic partnership with research organizations and medical institutions is projected to help the prominent players in expanding their consumer base. In addition, the growing focus on advanced in the medical sector is likely to contribute widely towards the development of the overall market in the next few years. However, the limited medical reimbursements for organ transplantation and donation are estimated to curb the growth of the overall market in the next few years.

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1786

According to the study, in 2012, the global market for organ preservation solutions was worth US$0.06 bn and is estimated to reach a value of US$0.20 bn by the end of 2019. Thanks to the rising awareness among consumers regarding the benefits of donation of organs, the global market is predicted to register a progressive 16.50% CAGR between 2013 and 2019.

The rising NGO and government initiatives to encourage organ donation and the increasing number of solid-organ transplantation procedures are some of the vital factors expected to fuel the growth of the global organ preservation solutions market in the near future. Additionally, the tremendously rising cases of organ failures worldwide and technological developments in this field are predicted to supplement the growth of the market. However, the high cost of organ transplantation is estimated to restrict the growth of the market in the near future.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1786

The integrated clinical analytics segment is also expected to exhibit a higher CAGR of 13.1% compared to the segment of stand-alone clinical analytics solutions, which is expected to expand at an 11.0% CAGR, over the period between 2016 and 2024. Of the overall global spending on clinical analytics solutions, spending on integrated solutions is expected to account for a 63% of the global market by 2024.

Integrated clinical analytics solutions observe higher demand owing to their highly dynamic nature and ability to extract data from clinical documents synched with the system, such as (electronic health records) EHR, utilizing the data to generate key insights. The relatively lower level of competency of stand-alone systems in terms of ability to integrate well with other data processing or managing systems will lead to their relatively lower adoption on a global front.

Report Details at https://www.transparencymarketresearch.com/organ-preservation-solutions.html

Furthermore, the rising number of organ donors and the policy of being an organ donor after death are some of the factors estimated to contribute towards the growth of the Europe market. The increasing awareness regarding the need for organ donation among the people and the rising number of initiatives taken by government to encourage organ donation are some of the other factors projected to fuel the growth of the market in the near future.

Some of the leading players operating in the organ preservation solutions market across the globe are Teva Pharmaceutical Industries Ltd., Claris Lifesciences Limited, BioTime, Inc., XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, Lifeline Scientific, CryoLife, Inc., ToleroTech, Inc., Bristol-Myers Squibb, BioLife Solutions, Inc., and 21st Century Medicine. The rising number of players in the market are projected to strengthen the competitive scenario of the global organ preservation solutions market in the next few years.

[elizabethmock1248-blog]

Biological Drugs Market Analysis and Opportunity Assessment to 2019

The biological drugs market has been demonstrating an upward movement since the last few years. The rising concerns over the increasing cases of side-effects caused by conventional medicines and drugs are having a positive impact on the demand for biological drugs across the world. The trend is expected to remain so over the forthcoming years with the opportunity in the worldwide biological drugs market expanding at a CAGR of 10.10% during the period from 2014 to 2020 and reaching US 287.1 bn by the end of the forecast period. 

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1694

Lantus, epogen, avonex, victoza, levemir, betaseron, enbrel, humalog, aranesp, neulasta, novolog, neupogen, rebif, and eylea are some of the main therapeutic proteins used in biological drugs. Enbrel has been witnessing a greater demand than other therapeutic proteins, worldwide. Enbrel is used in the treatment of auto-immune diseases, such as juvenile rheumatoid arthritis, plaque, psoriatic, and psoriasis. The growing prevalence of these diseases has influenced the sales of enbrel. 

Analysts expect the segment to rise at a CAGR of 14.50% over the forecast period. However, the concerns over side-effects of this protein, such as multiple sclerosis, tuberculosis, allergic reactions, and blood related infections, may limit its demand to some extent in the years to come. Lantus and neulasta are the other important therapeutic proteins, which are likely to gain impetus in the global market over the next few years. 

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1694

Report Details at https://www.transparencymarketresearch.com/biological-drugs-market.html

Europe and Asia Pacific are also projected to gain substantial momentum in their respective markets for biological drugs in the coming years, thanks to the growing awareness among consumers pertaining to the efficiency and other benefits of biological drugs. The unmet medical needs in Asia Pacific is also anticipated to add significantly to the growth of the global biological drugs market in the near future. 

GlaxoSmithKline Plc., Biogen Idec, Novartis AG, Baxter International Inc., Amgen Inc., Merck & Co. Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., Pfizer Inc. and Abbott Laboratories are some of the leading manufacturers of biological drugs across the world.

[elizabethmock1248-blog]

HIV Market Size, Share, Growth and Forecast to 2019

Human Immune-deficiency Virus (HIV) is one of the most widespread, catastrophic, incurable diseases among humans throughout the world. According to the 2013 report by World Health Organization (WHO), HIV ranked 6th among the global deaths throughout the world, with approximately 1,776,270 deaths in 2009 itself. HIV presents itself as a complex mix of symptoms, all related to severe immune compromise. The global HIV market, according to the Financial Times 2015, was around USD 20 billion in 2013, which ranks it along with the global insulin market. High quality global journalism requires investment. Globally, the annual deaths from HIV/AIDS have fallen from 2.3 million in 2005 to 1.5 million in 2013, according to the UN AIDS report. HIV antivirals are the largest segment of drugs in the HIV market. Pharmaceutical companies however are focusing on the research and development of novel drugs that prove to be a long term cure for HIV virus and shall forever suppress the virus throughout the life of an individual. 

Get Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=113

Treatments also involve dietary modifications and symptomatic relief of conditions presented during the onset of AIDS. Therapeutic treatment is often costly and requires constant supply of energy compounds (sugar/fat) in order for the patient to maintain a standard daily requirement.  The affordability of such treatments is a factor of concern in many developing countries of the world. Furthermore, highest number of HIV-infected people is witnessed in poor countries. There is a majority of the HIV infected population living in sub-Saharan Africa region. Hence, worldwide healthcare companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.

Get Discount on Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=113

The key regions methodically examined in the research report are North America, Asia Pacific, Europe, and Rest of the World. North America will be a lucrative market throughout the forecast horizon. The growth of the region can be attributed to the increasing initiatives by governments for immunization against diseases such as HPV and influenza along with a large number of private and public organizations pouring funds into the research and development of novel vaccines. Moreover, the presence of advanced and well-established healthcare infrastructure and facilities is providing a fillip to the growth of the region.

Asia Pacific is anticipated to rise at a noteworthy CAGR during the same period, primarily owing to the expanding base of patients coupled with high unmet clinical needs. Emerging countries such as China and India will be the major revenue contributors to the growth of the region. The rising disposable income and growing awareness regarding the benefits of vaccines are fuelling the growth of the region.

Report Details at https://www.transparencymarketresearch.com/hiv-market.html

Some of the well known companies manufacturing HIV drugs are: Bristol-Myers Squibb Company, ViiV Healthcare (Pfizer Inc.) and GlaxoSmithKline plc, Gilead Sciences Inc., Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG), F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Janssen Therapeutics, Merck & Co. Inc., Cipla Limited, and others, to name a few.

[elizabethmock1248-blog]

Personalized Cancer Genome Sequencing Market: Constant Advances in Next-Generation Sequencing Technology Open Promising Prospects

A new report by Transparency Market Research (TMR), titled “Personalized Cancer Genome Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024”, presents elaborate insights into key market dynamics, prominent trends, recent technology advances, innovations, lucrative prospects, and the competitive landscape.

Browse Report with TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12248

Relentless research in genetic engineering and the rising popularity of next generation genome sequencing in oncology in various parts of the world are striking trends supporting the evolution of the market. The rise in prevalence of various cancer types among populations in various developing and developed regions is a crucial factor catalyzing the growth of the personalized cancer genome sequencing market. The rising use of cost-effective next-generation sequencing to guide the search for personalized therapies is a notable trend that will aid in the robust growth of the market.

Request to View Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12248

Constant and rapid advancements in genomic sequencing methods will continue to fuel the growth of the market in the coming years. The growing number of clinical trials to unearth the potential of personalized cancer genome sequencing method is a welcome trend that will accentuate the global market in the years to come.

Geographically, North America, led by the U.S., is expected to contribute substantial revenues in the global market. In addition, Europe is a prominent market expected to witness substantial developments in personalized cancer genome sequencing methods in the coming years. The presence of a robust healthcare infrastructure backed by vigorous governmental funding in various countries of North America accounts for its prominence. Furthermore, stringent regulatory norms in these regions may be a promising avenue in the disguise of challenges for market players to capitalize on.

Meanwhile, Asia Pacific is an attractive regional market expected to witness substantial technology developments in the market in the next few years. Rising healthcare spends in various parts of the region and a booming medical tourism in countries such as India and China are significant factors boosting this regional market.

Key players operating in the personalized cancer genome sequencing market include BGI Americas Corporation, Cofactor Genomics, Illumina, Inc., Beckman Coulter Genomics, and Ambry Genetics.

Enquiry for discount on this report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12248

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com

[elizabethmock1248-blog]

Nanotechnology Drug Delivery Market Driven by Mushrooming SMEs to Harness New Possibilities

A recent business intelligence publication by Transparency Market Research (TMR) has notified that the emerging field of nanotechnology, which is a branch of technology that works with tolerances and dimensions of less than 100 nanometers, is primed to revolutionize the way drugs are delivered to a patient. The eventual location of drug delivery goes a long way in providing efficient care and consequently, a number of research and development activities are currently underway to harness the possibilities. The report, titled “Nanotechnology Drug Delivery Market (By Technology - Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; By Application - Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023,” has projected the demand to expand at an impressive CAGR of 12.5% during the forecast period of 2015 to 2023.

Browse Report with TOC @ https://www.transparencymarketresearch.com/report-toc/1822

The analysts of the report have highlighted the Eurostat comprehensive data that has estimated that nano-medicine industry in the European Union have 38 large pharmaceutical companies, 64 small and medium enterprises (SMEs), and 97 startups. This mushrooming number of companies who are indulged into the R&D activities of nanotechnology drug delivery is the primary driver of the market for the same. In addition to that, a number of leading pharmaceutical companies are collaborating to share technologies to harness newer possibilities, and thereby fueling the market. Prevalence of various chronic diseases, escalating percentage of geriatrics in the global population, and government support to find cure to widespread diseases are some of the other factors augmenting the demand in the global nanotechnology drug delivery market. On the other hand, stringent regulatory scenario and extremely high cost of medicines made using nanotechnology are obstructing the market from attaining its true potential.

Request to View Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1822

Based on technology, the nanotechnology drug delivery market can be segmented into nanoparticles, nanocrystals, micelles, liposomes, nanotubes, and others. Currently, the nanoparticles segment provides for the maximum demand, which is a reflection of strong demand for gold nanoparticles, dendrimers, and fullerenes. Application-wise, the market can be bifurcated into oncology, neurology, physiology or cardiovascular, immunology or anti-inflammatory, anti-infective, and others. Currently, anti-infective segment provides for the maximum demand, gaining traction from the rising prevalence of community-based infections.

Geographically, North America is the most lucrative region in the global nanotechnology drug delivery market, which is a reflection of the presence of a large number of pioneering companies in the country of the U.S. Growing prevalence of cancer and diabetes, favorable government policies for biotechnology and pharmaceutical manufacturers, and high adoptability rate of new technologies are some of the other factors driving the North America nanotechnology drug delivery market. The researchers have also highlighted Latin America as a region of strong potential on the back of increasing interest of some of the prominent companies such as Johnson & Johnson and Novartis in this region.

As far as the competitive landscape is concerned, the market for nanotechnology drug delivery is consolidated in nature, with a small chunk of players holding the major shares. The report identifies Johnson & Johnson, Amgen, Inc., AbbVie, Inc., Celgene Corporation, Merck & Co., Inc., and Novartis International AG as some of the key companies currently ahead of the curve. However, an increasing number of startups are mushrooming across the world, which will not only eat into the shares of the leading companies but also expand the market at a quicker rate. For the key companies to maintain their stronghold, the analysts of the report have anticipated a number of mergers and acquisitions to unfold in the near future.

Enquiry for discount on this report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1822

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com